These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18362505)

  • 1. Young elite athletes of different sport disciplines present with an increase in pulsatile secretion of growth hormone compared with non-elite athletes and sedentary subjects.
    Ubertini G; Grossi A; Colabianchi D; Fiori R; Brufani C; Bizzarri C; Giannone G; Rigamonti AE; Sartorio A; Muller EE; Cappa M
    J Endocrinol Invest; 2008 Feb; 31(2):138-45. PubMed ID: 18362505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.
    Sartorio A; Marazzi N; Agosti F; Faglia G; Corradini C; De Palo E; Cella S; Rigamonti A; Muller EE
    J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-, age-, body composition- and training workload-dependent differences of GH response to a discipline-specific training session in elite athletes: a study on the field.
    Sartorio A; Agosti F; Marazzi N; Trecate L; Silvestri G; Lafortuna C; Cappa M; De Palo E; Faglia G; Corradini C; Cella S; Rigamonti A; Müller EE
    J Endocrinol Invest; 2004 Feb; 27(2):121-9. PubMed ID: 15129806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting.
    Healy ML; Dall R; Gibney J; Bassett E; Ehrnborg C; Pentecost C; Rosen T; Cittadini A; Baxter RC; Sönksen PH
    J Clin Endocrinol Metab; 2005 Feb; 90(2):641-9. PubMed ID: 15546908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test.
    Ehrnborg C; Lange KH; Dall R; Christiansen JS; Lundberg PA; Baxter RC; Boroujerdi MA; Bengtsson BA; Healey ML; Pentecost C; Longobardi S; Napoli R; Rosén T;
    J Clin Endocrinol Metab; 2003 Jan; 88(1):394-401. PubMed ID: 12519882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.
    Guha N; Erotokritou-Mulligan I; Burford C; Strobridge G; Brigg J; Drake T; Bassett EE; Cowan D; Bartlett C; Sönksen PH; Holt RI
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2969-76. PubMed ID: 20410221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased pulsatility, process irregularity, and nocturnal trough concentrations of growth hormone in amenorrheic compared to eumenorrheic athletes.
    Waters DL; Qualls CR; Dorin R; Veldhuis JD; Baumgartner RN
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1013-9. PubMed ID: 11238479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in serum growth hormone (GH)/GH dependent ternary complex components (IGF-I, IGFBP-3, ALS, IGF-I/IGFBP-3 molar ratio) and the influence of these alterations on growth pattern in female rhythmic gymnasts.
    Adiyaman P; Ocal G; Berberoğlu M; Evliyaoğlu O; Aycan Z; Cetinkaya E; Bulca Y; Ersöz G; Akar N
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):895-903. PubMed ID: 15270408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes.
    Nelson AE; Howe CJ; Nguyen TV; Leung KC; Trout GJ; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4424-32. PubMed ID: 16912136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sexually dimorphic pattern of growth hormone secretion in the elderly.
    Hindmarsh PC; Dennison E; Pincus SM; Cooper C; Fall CH; Matthews DR; Pringle PJ; Brook CG
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2679-85. PubMed ID: 10443659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome.
    Garcia-Rudaz MC; Ropelato MG; Escobar ME; Veldhuis JD; Barontini M
    Eur J Endocrinol; 2002 Aug; 147(2):207-16. PubMed ID: 12153742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise-induced effects on growth hormone levels are associated with ghrelin changes only in presence of prolonged exercise bouts in male athletes.
    Sartorio A; Morpurgo P; Cappiello V; Agosti F; Marazzi N; Giordani C; Rigamonti AE; Muller EE; Spada A
    J Sports Med Phys Fitness; 2008 Mar; 48(1):97-101. PubMed ID: 18212716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: insulin-like growth factor I and procollagen type III peptide.
    Abellan R; Ventura R; Pichini S; Di Giovannandrea R; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2006 Dec; 27(12):976-83. PubMed ID: 16612742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH;
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of physical fitness and endurance exercise on indirect biomarkers of growth hormone and insulin misuse: Immunoassay-based measurement in urine samples.
    Pichini S; Ventura R; Palmi I; di Carlo S; Bacosi A; Langohr K; Abellan R; Pascual JA; Pacifici R; Segura J; Zuccaro P
    J Pharm Biomed Anal; 2010 Dec; 53(4):1003-10. PubMed ID: 20674210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous versus intermittent exercise, obesity, and gender on growth hormone secretion.
    Weltman A; Weltman JY; Watson Winfield DD; Frick K; Patrie J; Kok P; Keenan DM; Gaesser GA; Veldhuis JD
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4711-20. PubMed ID: 18782875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.